← Open Payments lookup

MELODIE YOUNG: Open Payments

NPI 1356379218 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$167,036 in 420 payments from 28 companies in 2025. Trend: 2023 $201,185 · 2024 $174,438 · 2025 $167,036

Speaker / faculty: $80,291Consulting: $58,339Travel & lodging: $10,842Honoraria: $6,300Food & beverage: $5,794Speaker / faculty: $5,343
CompanyPaymentsAmount
Lilly USA, LLC81$50,922
Arcutis Biotherapeutics, Inc.61$28,702
Janssen Biotech, Inc.28$20,126
Eli Lilly and Company30$16,735
UCB, Inc.38$16,116
Organon LLC16$7,427
SUN PHARMACEUTICAL INDUSTRIES INC.34$7,039
Kowa Pharmaceuticals America, Inc.7$5,485
Takeda Pharmaceuticals U.S.A., Inc.12$5,149
LEO Pharma Inc.11$3,054

Products named: EBGLYSS, Zoryve, TREMFYA, Bimzelx, VTAMA, ILUMYA, TALTZ, OTEZLA.

Industry payments across TX — which companies pay providers there.